American Society of Hematology 2022

American Society of Hematology 2022
December 10-13, 2022
New Orleans, LA

American Society of Hematology 2022.

Explore more information for Gilead Oncology therapies
Results (2)

Nature of Clinical Response and Depth of Molecular Response in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Treated with Magrolimab with Azacitidine

Magrolimab in Combination With Rituximab + Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma